Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. CSL Behring GmbH
483
•CSL Behring GmbH•February 18, 2026

CSL Behring GmbH – FDA 483, Feb 18, 2026

Record Details

CSL Behring GmbH, located in Marburg, Germany, underwent an FDA inspection from February 9 to February 18, 2026. The inspection of this licensed biological drug manufacturer revealed several significant violations of quality and safety standards across multiple marketed products, including Haegarda, Kcentra, and Humate-P. A primary concern involved an unverified change to the material of vial stoppers. The company failed to perform necessary compatibility studies to ensure the new material worked with medical transfer devices. This oversight led to a significant increase in global complaints where patients were unable to puncture the stoppers, resulting in bent device spikes, treatment delays, and dosing errors. Despite internal data confirming the material change was the root cause, the firm failed to report these biological product deviations to the FDA as required. Additionally, the FDA noted deficiencies in complaint management and manufacturing hygiene. The company frequently downplayed the severity of patient issues and delayed corrective actions for years. Investigators also found that the firm failed to re-validate equipment cleaning procedures after experiencing bacterial contamination in the production line. Finally, the quality unit was cited for excessive delays in closing internal investigations. Under the regulatory framework of the Food, Drug, and Cosmetic Act, these observations require CSL Behring to implement comprehensive corrective actions. The firm is expected to respond to the FDA with a plan to resolve these deficiencies to ensure compliance with drug safety and manufacturing standards.

Company
CSL Behring GmbH
Inspection date
February 18, 2026
Product type
biologics
Office
Baltimore District Office
People
  • Travis S. Bradley
  • Burnell M. Henry (Investigator)
View Company Profile

ID · a52ee712-3527-4a31-8ddd-fa0d417ab274

Violation Codes2
FD&C Act 704(b)21 U.S.C. 374(b)

Full citation text and observation details available on the Dashboard.

Other documents for CSL Behring GmbH
  • 483 - 2024-04-30April 30, 2024
  • 483 - 2024-04-18April 18, 2024
  • EIR - 2022-03-04March 4, 2022
  • 483 - 2022-03-04March 4, 2022
  • 483 - 2018-05-17May 17, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore CSL Behring GmbH
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.